Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 22
U.K. Plaintiffs Oppose Merck's Forum Non Conveniens Motion to Dismiss
Jury Finds for Merck in Federal Vioxx Product Liability Trial
New Jersey Judge Rejects Merck Effort to Sever Trial Cases
Merck Urges Court to Reject Vioxx Trial Consolidation Plan
Arthritis Drugs - Issue: 21
Merck Appealing Vioxx Third-Party Payor Class Certification
FDA Says Rule 45 Precludes MDL Plaintiffs' Subpoena of Dr. David Graham
Judge Dismisses Adequately Pled Arthritis Drug Case, Orders Separate Claims
Vioxx MDL Judge Grants Two Merck Daubert Motions
